Product Description
Basic Info.
Composition: It is a fixed-dose combination of the long-acting amylin analog Cagrilintide and the glucagon-like peptide-1 receptor agonist Semaglutide.
Mechanism of action: Cagrilintide, as an amylin receptor agonist, can significantly suppress appetite and effectively delay gastric emptying; Semaglutide, as a GLP-1 receptor agonist, can significantly enhance insulin secretion and strongly inhibit the release of glucagon.
At the same time, it further slows gastric emptying. The combination of the two is excellent in blood sugar control and weight management.

“Strength builds the foundation, and excellent services reach all over the world.”
create win-win situation with customers
We have cooperated with experienced shipping forwarders for many years, they arrange the shipment. No matter by express, by air or by sea, we will track the course of the goods all the way, to make sure goods arrive at you on time and in good condition.